Navigation Links
Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
Date:4/13/2009

Chief Executive Officer and Co-Founder of Raptor, commented, "As a clinical-stage company with multiple active programs, we are pleased to welcome Dr. Rioux. This is an ideal time for Patrice to join Raptor. We believe his successful clinical and regulatory track record will serve us well as we prepare for a pivotal clinical trial in our lead clinical program, DR Cysteamine in cystinosis, and position us to advance our other clinical-stage programs through the clinic and into the market."

Dr. Rioux said, "I am excited to join the team at Raptor, as I believe in the potential of the Company's pipeline of clinical-stage drug candidates that address some serious unmet medical needs."

Status of Raptor's Clinical-Stage Development Programs

Under Dr. Rioux' guidance, the Company expects to conduct its pivotal clinical study for DR Cysteamine in cystinosis in the second half of 2009 and file an NDA in 2010.

In February, 2009, Raptor announced the completion of patient enrollment in its Phase 2a open-label clinical trial to evaluate a prototype formulation of DR Cysteamine in juvenile patients diagnosed with NASH. Results from that study are expected later this year.

In November, 2008, Raptor entered into an agreement with the Centre Hospitalier Universitaire d'Angers ("CHU d'Angers") of France to evaluate DR Cysteamine in a two-year, multi-center Phase II clinical trial in Huntington's, sponsored by CHU d'Angers and supported by a grant from the Programme Hospitalier de Recherche Clinique - National, a program under the French Ministry of Health. Initiation of the Phase II Huntington's study, in which Raptor will supply the study drug, is planned for late 2009.

Also in November 2008, Raptor announced results of its Phase 2a study of Convivia in 32 ALDH2-deficient subjects of Japanese descent. The Company is actively exploring partnering opportunities for Convi
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
2. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
3. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
4. Raptor Pharmaceuticals Provides Update on Targeting Platforms
5. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
6. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
7. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
8. Raptor Pharmaceuticals Provides Update of Product Programs
9. Strativa Pharmaceuticals Provides Product Pipeline Update
10. Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009
11. Arena Pharmaceuticals to Host Conference Call and Webcast on Monday, March 30, 2009 to Discuss Lorcaserin Pivotal Phase 3 Obesity Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , August 27, 2014 ... Market By Products (Dental Radiology, CAD/CAM, Dental Chairs, Dental Lasers), Current ... by MarketsandMarkets, the global Dental Equipment Market is expected ... million in 2014, growing at a CAGR of ... 95 market data tables and 61 figures spread ...
(Date:8/27/2014)... 27, 2014 Reportlinker.com announces that a ... catalogue: Global Heart Valve Repair and ... About Heart Valve Repair and ... heart which control the flow of blood during ... valve diseases such as valvular stenosis, valvular insufficiency ...
(Date:8/27/2014)... 2014  Hill-Rom Holdings, Inc. (NYSE: HRC ... at the Morgan Stanley Global Healthcare Conference on September ... are invited to listen to the live discussion via ... it directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP .  A recorded replay ... conclusion of the live event and accessible at the ...
Breaking Medicine Technology:Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3Global Heart Valve Repair and Replacement Market 2014-2018 2Global Heart Valve Repair and Replacement Market 2014-2018 3Global Heart Valve Repair and Replacement Market 2014-2018 4
... Reportlinker.com announces that a new market ... Depression Therapeutics - Pipeline ... http://www.reportlinker.com/p0656880/Depression-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... Forecasts to 2018 Summary ...
... LAKE, N.J., Oct. 14, 2011 Par Pharmaceutical, Inc., ... PRX ) today announced that it filed ... injunction in U.S. District Court in Washington, D.C. seeking ... information to physicians and other healthcare providers about the ...
Cached Medicine Technology:Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 2Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 3Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 4Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 5Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 6Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 7Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 8Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 9Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 10Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES 2Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES 3Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES 4
(Date:8/27/2014)... For those who want to ... hosting products are very practical. Top10BestSEOHosting.com today announces ... are the best ASP.NET hosting suppliers of this ... a top web hosting provider for a long ... it today. Recently proclaimed one of the fastest ...
(Date:8/27/2014)... 2014 Delta, a reliable supplier of ... practical Cat D7R Dozers to its used bulldozer ... has announced that all these items are offered with ... to expand Delta’s market share in the coming September. ... the special offer; he has much confidence in the ...
(Date:8/27/2014)... UWDress.com, a popular supplier of wedding dresses and special ... of elegant bridesmaid dresses . There are more ... company's new and old customers can get a discounted ... This experienced company focuses on affordable clothes only. Its ... backless party outfits, princess wedding gowns and many others. ...
(Date:8/27/2014)... Taking its popular obstacle race to a new ... will host its largest crowd at its 3rd Annual ... YMCA Camp Thunderbird . , Hundreds of ... and teams. Within each division, runners will attempt to conquer ... for a worthy cause. All proceeds will fund scholarships ...
(Date:8/27/2014)... August 27, 2014 Reviewing the prices ... now be easier for the public when using the ... are promoted in all 50 states in the U.S. ... The different insurers that are generating the rates information ... for adults to use the programmed system without charge. ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Releases the Best ASP.NET Hosting Suppliers of This Year: Hostgator, Arvixe and FatCow 2Health News:Reliable Supplier Delta Adds New Items To Its Used Bulldozer Collection 2Health News:Elegant Bridesmaid Dresses For 2014 Now Available At UWDress.com 2Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2Health News:Home Insurance Prices for All 50 States Now Supplied at Consumer Insurance Portal Online 2
... Services Is Anti-Competitive and Harmful to Patients and SeniorsARLINGTON, ... the American Association for Homecare and 27 regional and ... Health Reform and the leadership of the Department of ... and Medicaid Services (CMS) to review and rescind the ...
... Heart Association, with support from the Jon Holden DeHaan ... study the development and mechanisms of generating new cardiac ... centers will be conducting studies to ultimately determine how ... heart attack and heart failure patients.The grants total $6 ...
... risk of chronic obstructive pulmonary disease , , , ... smoke cigarettes and marijuana increase their risk of ... pot alone doesn,t seem to increase the risk ... Chronic obstructive pulmonary disease (COPD) is a progressive ...
... Package Health IT FundingCHICAGO, April 13 Critical ... are far less likely now to develop complications ... since the health system implemented an advanced information ... treated from 2006-2008 at 13 Resurrection ICUs, presented ...
... PHILADELPHIA, April 13 The Mobile Massage Team ( ... seated massage services for corporate wellness programs, promotional events, ... be exhibiting at the Penjerdel Employee Benefits and Compensation ... at the Philadelphia Marriott Downtown, Wednesday, April 22, 2009. ...
... 17, 10AM , INSTITUTES FOR ... Demonstration During ... April 13 Four-Star General Barry McCaffrey, the former White House Drug ... and Dr. Barry Karlin, CEO of CRC Health Group, the nation,s largest ...
Cached Medicine News:Health News:Homecare Associations Nationwide Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule 2Health News:Homecare Associations Nationwide Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule 3Health News:Homecare Associations Nationwide Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule 4Health News:Homecare Associations Nationwide Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule 5Health News:Homecare Associations Nationwide Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule 6Health News:Homecare Associations Nationwide Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule 7Health News:Three Medical Centers Awarded Funds to Study Generation of Cardiac Muscle Cells 2Health News:Pot, Cigarette Smoke Wreaks Havoc on Lungs 2Health News:Resurrection Health Uses Information Technology to Address Critical Care Crisis 2Health News:Ex-White House Drug Czar McCaffrey, U.S. Congress Drug Caucus Chair Cummings, CRC Health CEO Karlin Join Hopkins Researchers at News Conference April 17 on Breakthrough Study: Internet Video Drug Treatment as Effective as Traditional Counseling 2Health News:Ex-White House Drug Czar McCaffrey, U.S. Congress Drug Caucus Chair Cummings, CRC Health CEO Karlin Join Hopkins Researchers at News Conference April 17 on Breakthrough Study: Internet Video Drug Treatment as Effective as Traditional Counseling 3
The BARDEX I.C. Catheter represents Bard's newest technology in providing protection against NUTI....
Used for injection into urethral strictures, bladder neck contracture, and the bladder wall. Supplied sterile in peel-open packages. Intended for one-time use....
... a minimally invasive tension-free sling specifically ... resulting from urethral hypermobility (Type II) ... TF Kit is designed to accommodate ... Supplied sterile in peel-open packages. ...
... the lower ureter and inject ... submucosal tunneling. Also used to ... the ureter. The tapered tip ... of a ureteral stone. Supplied ...
Medicine Products: